Real-world clinical experience of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in hypertension: the EXCITE study

201421 citationsJournal Article

Authors

Jorge Sison · Chinese General Hospital and Medical Center

Samir H. Assaad‐Khalil · Alexandria University

Robert Najem · Lebanese University

Asad Riaz Kitchlew · Pakistan Institute of Medical Sciences

Belong Cho · Seoul National University

Kwo‐Chang Ueng · Chung Shan Medical University Hospital

Abhijit Shete

Abstract

The EXCITE study provides evidence that Aml/Val and Aml/Val/HCT provide clinically meaningful BP reductions and are well tolerated in a large multi-ethnic hypertensive population studied in routine clinical practice.

Topics & Keywords

Blood Pressure and Hypertension Studies Pharmaceutical Practices and Patient Outcomes Medication Adherence and Compliance

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Current Medical Research and Opinion

Volume 30, Issue 10, pp. 1937-1945

DOI: 10.1185/03007995.2014.942415

Field-Weighted Citation Impact: 1.38